Barclays Keeps Their Buy Rating on Xeris Pharmaceuticals (XERS)
at www.tipranks.com (Wed, 11-Nov 4:16 AM)
Xeris lifts 2030 revenue outlook to more than $1 billion as Recorlev grows 93% year-over-year
Market Chameleon (Thu, 5-Nov 7:51 AM)
Xeris uses inducement equity plan to hire 60 employees, granting 352,170 shares in options and RSUs
Market Chameleon (Mon, 5-Oct 11:49 AM)
